Minimization of Transplant Immunosuppression: An Elusive Goal.
作者信息
Lee Brian K, Han Hwarang S, Adler Joel T
机构信息
Division of Nephrology, Department of Medicine, Dell Medical School, University of Texas at Austin, Austin, TX.
Department of Surgery and Perioperative Care, Dell Medical School, University of Texas at Austin, Austin, TX.
出版信息
Transplantation. 2024 Jan 1;108(1):18-19. doi: 10.1097/TP.0000000000004737. Epub 2023 Aug 1.
Abstract
摘要
相似文献
1
Minimization of Transplant Immunosuppression: An Elusive Goal.移植免疫抑制的最小化：一个难以实现的目标。
Transplantation. 2024 Jan 1;108(1):18-19. doi: 10.1097/TP.0000000000004737. Epub 2023 Aug 1.
2
Immunosuppression Therapy in Kidney Transplantation.肾移植中的免疫抑制治疗。
Urol Clin North Am. 2022 May;49(2):345-360. doi: 10.1016/j.ucl.2021.12.010.
3
Immunosuppression minimization is safe and associated with good long-term success in pediatric recipients of liver transplant.免疫抑制最小化在肝移植的儿科受者中是安全的，并与良好的长期成功相关。
Liver Transpl. 2024 Jul 1;30(7):707-716. doi: 10.1097/LVT.0000000000000300. Epub 2023 Nov 8.
4
"Not too much, not too little, just right"-Finding the Goldilocks point in pediatric immunosuppression minimization.
Liver Transpl. 2024 Jul 1;30(7):676-677. doi: 10.1097/LVT.0000000000000334. Epub 2024 Jan 26.
5
Immunosuppression and Kidney Transplantation.免疫抑制与肾移植。
Handb Exp Pharmacol. 2022;272:165-179. doi: 10.1007/164_2021_546.
6
Belatacept in the treatment of acute T-cell mediated rejection and maintenance immunosuppression in a paediatric kidney transplant recipient.贝拉西普用于治疗儿童肾移植受者的急性T细胞介导的排斥反应及维持免疫抑制。
Nephrology (Carlton). 2022 Jul;27(7):641-642. doi: 10.1111/nep.14036. Epub 2022 Mar 14.
7
Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?HIV感染的肾移植受者的诱导免疫抑制：是否进行淋巴细胞清除？
Transpl Infect Dis. 2024 Aug;26(4):e14299. doi: 10.1111/tid.14299. Epub 2024 Jul 2.
8
Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial.肾移植中 2 种免疫抑制最小化策略的比较：ALLEGRO 试验。
Transplantation. 2024 Feb 1;108(2):556-566. doi: 10.1097/TP.0000000000004776. Epub 2024 Jan 19.
9
Assessing Long-Term Adverse Outcomes in Older Kidney Transplant Recipients: A Propensity Score-Matched Comparison of Early Steroid Withdrawal Versus Continuous Steroid Immunosuppression Using a Large Real-World Database.评估老年肾移植受者的长期不良结局：使用大型真实世界数据库进行的早期撤激素与持续激素免疫抑制的倾向评分匹配比较。
Drugs Aging. 2024 Nov;41(11):915-927. doi: 10.1007/s40266-024-01147-4. Epub 2024 Oct 17.
10
Immunosuppression in solid organ-transplant recipients and impact on nutrition support.实体器官移植受者的免疫抑制及其对营养支持的影响。
Nutr Clin Pract. 2024 Feb;39(1):109-116. doi: 10.1002/ncp.11099. Epub 2023 Nov 29.
本文引用的文献
1
Tacrolimus After rATG and Infliximab Induction Immunosuppression-RIMINI Trial.他克莫司在 rATG 和英夫利昔单抗诱导免疫抑制后的应用-RIMINI 试验。
Transplantation. 2024 Jan 1;108(1):242-251. doi: 10.1097/TP.0000000000004736. Epub 2023 Aug 1.
2
OPTN/SRTR 2021 Annual Data Report: Kidney.OPTN/SRTR 2021 年度数据报告：肾脏。
Am J Transplant. 2023 Feb;23(2 Suppl 1):S21-S120. doi: 10.1016/j.ajt.2023.02.004.
3
Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients: Results of the CTOT-19 Trial.英夫利昔单抗诱导治疗在尸肾移植受者中缺乏疗效并增加 BK 病毒感染：CTOT-19 试验的结果。
J Am Soc Nephrol. 2023 Jan 1;34(1):145-159. doi: 10.1681/ASN.2022040454. Epub 2022 Oct 4.
4
Clinical Significance of Mycophenolate Mofetil Withdrawal in Kidney Transplant Recipients.霉酚酸酯撤药在肾移植受者中的临床意义
Transplant Proc. 2019 Oct;51(8):2633-2636. doi: 10.1016/j.transproceed.2019.03.061. Epub 2019 Aug 22.
5
Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.新发供者特异性抗体的肾移植受者移植物失功进展的发生率及决定因素
Am J Transplant. 2015 Nov;15(11):2921-30. doi: 10.1111/ajt.13347. Epub 2015 Jun 10.
6
Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.免疫稳定的肾移植受者停用他克莫司的不良后果。
J Am Soc Nephrol. 2015 Dec;26(12):3114-22. doi: 10.1681/ASN.2014121234. Epub 2015 Apr 29.
7
OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation.OSAKA 试验：一项比较肾移植中他克莫司 QD 和 BD 的随机对照试验。
Transplantation. 2013 Nov 27;96(10):897-903. doi: 10.1097/TP.0b013e3182a203bd.
8
Role of TNFalpha in early chemokine production and leukocyte infiltration into heart allografts.肿瘤坏死因子-α在早期趋化因子产生和白细胞浸润心脏移植中的作用。
Am J Transplant. 2010 Jan;10(1):59-68. doi: 10.1111/j.1600-6143.2009.02921.x. Epub 2009 Dec 2.
9
Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions.嵌合抗TNF-α单克隆抗体cA2可结合重组跨膜TNF-α并激活免疫效应功能。
Cytokine. 1995 Apr;7(3):251-9. doi: 10.1006/cyto.1995.0029.
Zotero 插件